Colorectal cancer statistics, 2020
By R. Siegel, K. Miller, Ann Goding Sauer, S. Fedewa, L. Butterly, Joseph C. Anderson, A. Cercek, Robert A. Smith, A. Jemal. Ca, 2020
4,289 citations recorded by the source corpus.
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population‐based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening‐aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non‐Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.
Subfields: Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/e6f53de8c8ab9cc2afdb6a75518a33a9f17f652b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- ACG Clinical Guidelines: Colorectal Cancer Screening 2021. (2021, background): “A study estimated that in 2020 approximately 147,950 new CRC cases would have been diagnosed and 53,200 individualswould have died of the disease (1).”
- Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. (2021, methodology): “For KQ1, the syntheses were organized into 3 main categories: (1) trials designed to assess the effectiveness (intention to screen) of screening tests compared with no screening; (2) observational studies designed to assess the association of receipt of a screening test compared with no screening; a”